Human Tumor necrosis factor ligand superfamily member 14(TNFSF14) ELISA kit

Code CSB-EL023991HU
Size 96T,5×96T,10×96T
See More Details 24T ELISA kits trial application
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Target Name tumor necrosis factor (ligand) superfamily, member 14
Alternative Names CD 258 ELISA Kit; CD258 ELISA Kit; CD258 antigen ELISA Kit; Delta transmembrane LIGHT ELISA Kit; Herpes virus entry mediator ligand ELISA Kit; Herpesvirus entry mediator A ELISA Kit; Herpesvirus entry mediator ligand ELISA Kit; herpesvirus entry mediator-ligand ELISA Kit; HVEM L ELISA Kit; HVEM-L ELISA Kit; HVEML ELISA Kit; Ligand for herpesvirus entry mediator ELISA Kit; LIGHT ELISA Kit; LTg ELISA Kit; soluble form ELISA Kit; TNF14 ELISA Kit; TNF14_HUMAN ELISA Kit; TNFSF 14 ELISA Kit; Tnfsf14 ELISA Kit; TNFSF14 protein ELISA Kit; TR 2 ELISA Kit; TR2 ELISA Kit; Tumor necrosis factor (ligand) superfamily; member 14 ELISA Kit; Tumor necrosis factor ligand superfamily member 14 ELISA Kit; Tumor necrosis factor ligand superfamily; member 14 ELISA Kit; Tumor necrosis factor receptor like 2 ELISA Kit; tumor necrosis factor receptor-like 2 ELISA Kit; Tumor necrosis factor superfamily member 14 ELISA Kit; Tumor necrosis factor superfamily member LIGHT ELISA Kit
Abbreviation TNFSF14
Uniprot No. O43557
Species Homo sapiens (Human)
Sample Types serum, plasma, urine
Detection Range 31.25 pg/mL-2000 pg/mL
Sensitivity 7.81 pg/mL
Assay Time 1-5h
Sample Volume 50-100ul
Detection Wavelength 450 nm
Research Area Others
Intra-assay Precision (Precision within an assay): CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess.
Inter-assay Precision (Precision between assays): CV%<10%
Three samples of known concentration were tested in twenty assays to assess.
To assess the linearity of the assay, samples were spiked with high concentrations of human TNFSF14 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
  Sample Serum(n=4)
1:1 Average % 88
Range % 84-92
1:2 Average % 102
Range % 94-107
1:4 Average % 95
Range % 89-99
1:8 Average % 92
Range % 88-96
The recovery of human TNFSF14 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
Sample Type Average % Recovery Range
Serum (n=5) 97 91-103
EDTA plasma (n=4) 89 82-94
Typical Data
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
pg/ml OD1 OD2 Average Corrected
2000 2.902 2.844 2.873 2.758
1000 2.007 2.167 2.087 1.972
500 1.218 1.246 1.232 1.117
250 0.664 0.676 0.670 0.555
125 0.397 0.384 0.391 0.276
62.5 0.243 0.258 0.251 0.136
31.25 0.165 0.169 0.167 0.052
0 0.114 0.115 0.115  
and FAQs
Storage Store at 2-8°C. Please refer to protocol.
Lead Time 7-14 working days

Target Data

Function Cytokine that binds to TNFRSF3/LTBR. Binding to the decoy receptor TNFRSF6B modulates its effects. Activates NFKB, stimulates the proliferation of T-cells, and inhibits growth of the adenocarcinoma HT-29. Acts as a receptor for Herpes simplex virus.
Gene References into Functions
  1. the outcomes of this study provide compelling evidence that TNFSF14 is necessary to limit relevant steps in the pathogenesis of the metabolic syndrome and support the development of agonists of TNFSF14 signaling as attractive therapeutics for treating obesity and type 2 diabetes PMID: 29359470
  2. LIGHT is highly expressed and companied with severe inflammations in patients with coronary disease. LIGHT significantly enhanced inflammation response in oxLDL-induced THP-1 macrophages. PMID: 28642135
  3. LIGHT and LTBR interaction increases the survival and proliferation of human bone marrow-derived mesenchymal stem cells, and therefore, LIGHT might play an important role in stem cell therapy. PMID: 27835685
  4. Serum LIGHT levels correlate with disease progression and severity in interstitial pneumonia patients with dermatomyositis. PMID: 26448572
  5. LIGHT, via LTbetaR signaling, may contribute to exacerbation of airway neutrophilic inflammation through cytokine and chemokine production by bronchial epithelial cells. PMID: 25501580
  6. LIGHT controls TSLP to drive pulmonary fibrosis. PMID: 25680454
  7. The tumor necrosis factor superfamily molecule LIGHT promotes keratinocyte activity and skin fibrosis. PMID: 25789702
  8. proliferation and migration would be enhanced in Tca8113 cells with over-expressed TNFSF14 PMID: 26146063
  9. LIGHT, a TNF superfamily member, is involved in T-cell homeostasis and erosive bone disease associated with rheumatoid arthritis. PMID: 25460501
  10. Crystal structures of LIGHT and the LIGHT:DcR3 complex reveal the structural basis for the DcR3-mediated neutralization of LIGHT. PMID: 25087510
  11. regulation by NK cell licensing helps to safeguard against TNFSF14 production in response to healthy tissues. PMID: 25512551
  12. The findings suggest a new molecular determinant of LIGHT-mediated pathogenic changes in human bronchial epithelial cells. PMID: 25251281
  13. TNFSF14 has an effect on the activation of basophils and eosinophils interacting with bronchial epithelial cells PMID: 24782592
  14. Triggering of LIGHT induced production of pro-inflammatory mediators such as interleukin-8 and matrix metalloproteinase-9 while suppressing the phagocytic activity. PMID: 24044961
  15. GG carriers of rs1077667, of the LIGHT gene, with the highest risk for Multiple Sclerosis, had the lowest serum levels. PMID: 23037546
  16. although a limited number of activated T-cells infiltrate the tumor and initiate an immune response, the number of LIGHT + T cells infiltrating the tumor is very low PMID: 23514280
  17. findings show that LIGHT is not inhibited by the soluble RANKL receptor OPG and that LIGHT is a potent osteoclastogenesis factor that activates the Akt, NFkappaB and JNK pathways PMID: 23391709
  18. TNFSF14 was significantly increased in sickle-cell anemia, SCA treated with hydroxycarbamide,& HbSC. It could contribute to endothelial activation & inflammation in SCA. PMID: 22775554
  19. This study showed that expression of the death-triggering ligand LIGHT is increased in ALS spinal cords PMID: 22221541
  20. increased plasma levels in patients with atopic dermatitis PMID: 22519595
  21. INF-gamma can synergistically precede LIGHT-induced apoptotic processes through down-regulation of Bcl-2 expression, but not survivin expression. PMID: 21117871
  22. These data clearly indicate that ZFP91 is a key regulator in LIGHT-induced activation of non-canonical NF-kappaB pathway in LTbetaR signaling. PMID: 20804734
  23. Herpes simplex virus 1 gD interfere HVEM function by competing with its natural ligands and by downregulating HVEM. PMID: 20826693
  24. Increased potential for LIGHT receptor signaling, coupled with increased bioavailability due to lower decoy receptor-3 (DcR3) avidity, provides a mechanism for polymorphic variants in LIGHT to contribute to the pathogenesis of inflammatory diseases. PMID: 20592286
  25. mediates organ-specific donor T cells activation in GVHD PMID: 19826934
  26. suppresses tumor growth by augmentation of immune response PMID: 19716382
  27. There is over expression of genes related to immune and inflammatory responses, including cytokines such as TNFSF14 in interstitial cystitis PMID: 20096889
  28. When highly expressed, LIGHT is capable of promoting effector T cell proliferation and differentiation even in a regulatory T (Treg) cell-enriched, suppressive intestinal environment. PMID: 20042587
  29. These findings suggested that LIGHT might be involved in the progression of inflammatory bone destruction in rheumatoid arthritis. PMID: 19019090
  30. Effects in transgenic mice indicate that human LIGHT may function as a major regulator of T cell activation, and implicate LIGHT signaling pathways in inflammation focused on mucosal tissues. PMID: 11714797
  31. LIGHT (TNFSF14),5 its membrane-anchored ligand, was also present in atheromatous lesions and highest in regions rich in macrophage-derived foam cells. PMID: 11742858
  32. Role of calcium-signaling pathway in the transcriptional control PMID: 12215452
  33. LIGHT may act as an anti-apoptotic agent against TNFalpha-mediated liver injury by blocking the activation of both caspase-3 and caspase-8. PMID: 12393901
  34. LIGHT, a new member of the TNF superfamily [review] PMID: 12456019
  35. Data show that mRNA encoding LIGHT and its receptors [HVEM, LTbetaR, and TR6 (DcR3)] are present in placentas and cytotrophoblast cells at term. PMID: 12466117
  36. Soluble LIGHT blocks TR6-Fc costimulated proliferation, lymphokine production, and cytotoxicity of T cells in the presence of T cell receptor ligation. PMID: 12471113
  37. LIGHT-sensitized IFN-gamma-mediated apoptosis of MDA-MB-231 cells is probably through down-regulation of anti-apoptosis Bcl-2 family members; it could be caspase (especially caspase-3)-independent, even though extensive caspase activation was observed. PMID: 12767529
  38. LIGHT signaling is mediated through both death receptor and mitochondria pathways PMID: 15115612
  39. LIGHT-herpesvirus entry mediator mediated signaling as an important immune regulatory mechanism in mucosal inflammatory responses. PMID: 15210782
  40. Mechanisms protecting trophoblast cells from LIGHT-mediated apoptosis were studied. PMID: 15215185
  41. LIGHT expression by human intestinal T cells suggests the possibility that LIGHT may play a key role in regulation of the mucosal immune system. PMID: 15634882
  42. LIGHT protein can be activated on mucosal T cells through a gut-specific CD2-dependent signaling mechanism. PMID: 15634882
  43. Data suggest that LIGHT constitutively expressed in human melanoma cells and microvesicles may contribute to regulate T-cell responses to tumor cells. PMID: 15833878
  44. NF-kappaB signal plays a key role in LIGHT-mediated upregulation of CD86 expression. PMID: 15895390
  45. both LTbetaR and HVEM can discriminatively mediate the expression of different genes in cultured human umbilical vein endothelial cells, including LIGHT, a proinflammatory cytokine PMID: 15917993
  46. A transgenic mouse model resembling Crohn's disease (CD) suggests that up-regulation of LIGHT may be an important mediator of CD pathogenesis. PMID: 15944326
  47. LIGHT could serve as a molecular link between lipid metabolism, inflammation, and thrombus formation, which are all features of atherosclerotic plaques. PMID: 16186421
  48. platelet-derived LIGHT is biologically active and can induce an inflammatory response in monocytes and particularly within endothelial cells measured as up-regulation of adhesion molecules and release of chemokines PMID: 16861346
  49. Blockade of TNFSF14 signaling caused a substantial reduction in the expression of lymphotoxin beta receptor (LTbetaR)-controlled migration factors within the islets and disrupts organization of tertiary structures, leading to prevention of diabetes. PMID: 16934497
  50. LIGHT system may regulate early to middle stages of placental development via cell-specific, temporally programmed expression of the ligand and its receptors, and may also assist in preserving placental immune privilege. PMID: 17010447
  51. in addition to activating NF-kappaB/p52, LIGHT also activates Stat3 through the NIK pathway PMID: 17543278
  52. attenuated Salmonella typhimurium expressing LIGHT inhibited growth of primary tumors, as well as the dissemination of pulmonary metastases, in various mouse tumor models employing murine carcinoma cell lines in immunocompetent mice PMID: 17652173
  53. The plasma levels of LIGHT seem to be similar in hemodialysis (HD) patients and healthy subjects and were not affected by gender, age, the mean period of HD history, disease etiology, type of medication and type of using dialysis membrane. PMID: 17826757
  54. platelet-associated LIGHT is involved in adhesion of platelets to endothelium while soluble LIGHT induces a pro-inflammatory state in vascular endothelial cells PMID: 17938804
  55. Lymphotoxin-beta receptor ligand LIGHT activates both the the noncanonical and classical NF-kappa B pathways leading to proinflammatory gene expression in vascular endothelial cells. PMID: 18292573
  56. the allele T of C-770T and the haplotype TTGA of the promoter SNPs in LIGHT gene might decrease the expression of LIGHT and subsequently increase the susceptibility to vascular dementia in females PMID: 18320356
  57. derangement of LIGHT may be important for atherogenetic process of ischemic stroke. PMID: 18384455
  58. LIGHT was upregulated in both synovial fluid and synovium of rheumatoid arthritis patients compared with osteoarthritis patients. PMID: 18412315
  59. LIGHT acts synergistically with PAR-2 activation to promote enhanced release of the proatherogenic interleukin-8 & monocyte chemoattractant protein-1. The interaction between LIGHT & PAR-2 is biologically active, promoting potent inflammatory effects. PMID: 19023130
  60. Enhanced plasma levels of soluble LIGHT in patients with chronic infections suggest a role of LIGHT in systemic inflammatory activation. PMID: 19380287
  61. unknown killing effect of LIGHT through HVEM on a lymphoid malignancy is described. PMID: 19701890

Show More

Hide All

Subcellular Location Tumor necrosis factor ligand superfamily member 14, membrane form: Cell membrane, Single-pass type II membrane protein, SUBCELLULAR LOCATION: Tumor necrosis factor ligand superfamily member 14, soluble form: Secreted, SUBCELLULAR LOCATION: Isoform 2: Cytoplasm
Protein Families Tumor necrosis factor family
Tissue Specificity Predominantly expressed in the spleen but also found in the brain. Weakly expressed in peripheral lymphoid tissues and in heart, placenta, liver, lung, appendix, and kidney, and no expression seen in fetal tissues, endocrine glands, or nonhematopoietic tu
Database Links

HGNC: 11930

OMIM: 604520

KEGG: hsa:8740

STRING: 9606.ENSP00000469049

UniGene: Hs.129708

Most popular with customers


Get all the latest information on Events, Sales and Offers. Sign up for newsletter today.

© 2007-2020 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1